Brief: Panacea Biotec Files Suit To Restrain Sanofi Healthcare From Marketing Fully Liquid Hexavalent Vaccine
17/05/2021 07:49
May 17 (Reuters) - Panacea Biotec Ltd PNCA.NS :
* FILED SUIT IN COURT TO RESTRAIN SANOFI HEALTHCARE INDIA
FROM
MARKETING FULLY LIQUID HEXAVALENT VACCINE
* SUIT TO RESTRAIN SANOFI HEALTHCARE FROM MARKETING VACCINE
THAT
WOULD INFRINGE CO'S PATENT FOR EASYSIX
Source text for Eikon: ID:nBSE7X8fCz
Further company coverage: PNCA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panacea Biotec
See all newsBrief: Panacea Biotec Receives Letter Of Award For BOPV Supply Worth $8.205 Million
Brief: Panacea Biotec Unit Gets Show Cause Notice Alleging Total Tax Liability Of 40.6 Million Rupees
Brief: Panacea Biotec Files Appeal Against Fourth Industrial Tribunal (Mohali) Award
India's Panacea Biotec rises to record high on EU-backed dengue vaccine project
India Stocks: Indian shares rise as banks gain on RBI forex swap facility